TMS in animal models: Methods and Applications
Alexander Rotenberg, M.D., Ph.D. Director, Neuromodulation Program Boston Children’s Hospital
Coil Electric field Magnetic field Electric current
Y P TMS in animal models: O Methods and Applications C T O - - PowerPoint PPT Presentation
Y P TMS in animal models: O Methods and Applications C T O Electric current Magnetic N field Electric Coil field O D E S A E Alexander Rotenberg, M.D., Ph.D. L P Director, Neuromodulation Program Boston Childrens Hospital Y
Coil Electric field Magnetic field Electric current
Poma et al., 2006
Liebetanz et al., 2003
Charlet de Sauvage et al. 2007
Valero Cabre et al., 2005
Valero-Cabre et al. 2006 20 Hz off-line 20 Hz on-line 1 Hz on-line
Kistsen et al., in progress
Luft et al., 2001 Kamida et al., 1998
Frye, Rotenberg, et al. Child Neurol 2007
Rotenberg et al., 2009 EMG EMG Ground
Roteberg, Goldie, Leroy (Vivonics Inc., and Boston Children’s Hospital)
Roteberg, Goldie, Leroy (Vivonics Inc., and Boston Children’s Hospital)
‐0.8 ‐0.7 ‐0.6 ‐0.5 ‐0.4 ‐0.3 ‐0.2 ‐0.1 0.1 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59
Control 10mg 20mg
MEP amplitude change (Log %baselne) Gersner et al., in progress
MEP amplitude change (Log %baselne)
‐0.8 ‐0.7 ‐0.6 ‐0.5 ‐0.4 ‐0.3 ‐0.2 ‐0.1 0.1 0.2 1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58 61 64 67 70 73 76 79 82 85 88 91 94 97 100 103
Log‐transformed
Control 2to1
Frye, Rotenberg, et al. Child Neurol 2007
1
Conditioning TMS 2 Test TMS
50 ms
Paired-pulse MEP inhibition
Rotenberg and Pascual-Leone, 2010
GABA-mediated inhibition
Accelerometer
MMG (V)
0.00 0.05 0.10 0.15 50ms
60%MO 70%MO 80%MO 90%MO 100%MO
MMG
Input–output curve of MMG
EMG (Tibia anterior m.)
200ms ISI
Condition
Pre P10 P60 Pre P10 P60 Pre P10 P60
% of unconditioned MMG
20 40 60 80 Saline PB PTZ
Left Right Ave (L+R)
*** * *** * *** *
reduced inhibition with PTZ and increased inhibition with PB
Annegers JF. Lippincott Williams & Wilkins, 2001:165-72.
(PTE)
Nature Protocols, 2011 McIntosh et al., 1989
Time
Pre 1WK 2WKS 3WKS 4WKS 5WKS 6WKS
Ratio
0.0 0.2 0.4 0.6 0.8 1.0 Sham control TBI
** * * * * *
4 2 Sham control TBI (lesion) 4 2 6 6
NeuN
4 2 TBI (contra-lesion) 6 I II/III V VI
NeuN Hsieh et al., Cerebral Cortex 2016
Gonchar et al., 2007, Front Neuroanat.
4 2 Sham control Post-TBI (peri-lesion) 4 2 6 6
PV
4 2 Post-TBI (contra-lesion) 6 I II/III V VI * *** *** * n.s. n.s. Peri-lesion Contra-lesion
8-oxo-dG
I II/III V VI 4 2 Sham control Post-TBI (peri-lesion) 4 2 6 6 4 2 Post-TBI (contra-lesion) 6
n.s. *** *** ** n.s. n.s. Peri-lesion Contra-lesion
(8-oxo-DG)
Hameed et al., in progress
2 weeks 4 weeks 6 weeks * * * p<0.05
Antioxidant (N‐acetylcysteine) Oxidative stress Loss of PV‐cells ↓ Perineuronal nets ↓ Otx2 Impaired inhibition Neuroprotection (Otx2) Lee et al., 2013
Frye, Rotenberg, et al. Child Neurol 2007
EEG analysis (seizure detection) coil electric current magnetic field electric field torso strap restraints
Rotenberg et al., Clin Neurophys 2008
rTMS during KA seizures
Relative Average Seizure Duration (% untreated control) 0.25 Hz
0% 25% 50% 75% 100% 125% 150%
0.5 Hz
0.75 Hz
untreated sham active
untreated sham active untreated sham active
Rotenberg et al., 2008
Combination therapy: lorazepam + rTMS in seizure suppression
½ LZP + Sham ½ LZP + ½ LZP ½ LZP + rTMS 2nd treatment Baseline LZP Follow-up 30 sec
0.2 0.4 0.6 0.8 1 1.2 1.4 BL 1st 2nd FU Normalized spike frequency (auto-count)
Baseline LZP Follow-up 2nd Treatment
Gersner et al., 2016.
½ LZP + sham TMS ½ LZP + ½ LZP ½ LZP + rTMS
1
50 100 150 c h a n g e H z
Rotenberg et al., unpublished data % reduction in Seizure Frequency After rTMS
Nakano et al., 2004
Muller et al., PLOS One 2014
*
1 0.5 0.25 S1 S0.5 S0.25
Stimulation Condition (Hz)
Reduced cortical excitability
0% 50% 100% 150% 200% 250% 300%
20 Hz rTMS Sham
pCREB (% control) 20 Hz rTMS Sham
anesthetized awake Gersner et al., J. Neursci 2011
Gersner et al., J. Neursci 2011
Hsieh et al., work in progress
Hsieh et al., work in progress
1 sec
MEA recording and TRANSCRANIAL FISH STIMULATION Meyer et al., SFN 2014
30 20 10
Cathode Anode
No CTEP +CTEP
Layer II/III Layer V/VI
Stimulating electrode Recording electrode
Support: NIH NINDS; NIH NIMH Department of Defense CIMIT Epilepsy Research Foundation Citizens United for Research in Epilepsy Boston Children’s Hospital Translational Research Program Children’s Hospital Department of Neurology Al Rashed family; Siegel family; Fisher Family
Nicolas Chiriboga Sameer Dhamne Roman Gersner Mustafa Hameed Tsung-Hsun Hsieh Harper Kaye Henry Lee Richard Manfready Michaela Meyer Paul Muller Carmen Paredes Maria Sanchez Yan Sun Andrew Vahabzadeh Jingpu Zhao
Colleagues and mentors Narong Auvichayapat ‐ Khon Kaen U., Thailand Paradee Auvichayapat ‐ Khon Kaen U., Thailand Marom Bikson ‐ CCNY Blaise Bourgeois ‐ BCH Dana Ekstein – Hadassah, Israel Felipe Fregni – Spaulding Rehab / MGH Joseph Gonzalez‐Heydrich ‐ BCH Takao Hensch ‐ BCH Frances Jensen – U Penn Anli Liu ‐ NYU Tobias Loddenkemper – BCH Joseph Madsen ‐ BCH Alvaro Pascual‐Leone – BIDMC Phil Pearl ‐ BCH Ann Poduri ‐ BCH James Riviello ‐ Columbia Paul Rosenberg – BCH Mustafa Sahin ‐ BCH Steve Schachter – CIMIT / BIDMC Don Schomer – BIDMC Mo Shafi ‐ BIDMC Masanori Takeoka ‐ BCH Abraham Zangen – BGU, Israel